Journal
GREEN CHEMISTRY
Volume 24, Issue 5, Pages 2010-2016Publisher
ROYAL SOC CHEMISTRY
DOI: 10.1039/d1gc02387j
Keywords
-
Funding
- National Scholarship Programme of the Slovak Republic
- EPSRC Centre for Doctoral Training in Critical Resource Catalysis (CRITICAT) [EP/L016419/1]
Ask authors/readers for more resources
The synthesis of chiral amines is a key reaction in chemical synthesis. Researchers are striving to develop more sustainable alternatives to metal-catalyzed methods currently used in various industries. By using N-phenylputrescine as an amine donor, a broad range of synthetically useful TA biocatalysts can be utilized under various reaction conditions, demonstrating its potential in practical applications like synthesizing pharmaceuticals such as sitagliptin.
The synthesis of chiral amines in enantioenriched form is a keystone reaction in applied chemical synthesis. There is a strong push to develop greener and more sustainable alternatives to the metal-catalysed methods currently used in the pharmaceutical, agrochemical and fine chemical industries. A biocatalytic approach using transaminase (TA or ATA) enzymes to convert prochiral ketones to chiral amines with unparalleled levels of enantioselectivity is highly appealing. However, the use of TA enzymes in synthesis is severely hampered by the unfavourable thermodynamics associated with the amine donor/acceptor equilibrium. Several 'smart' amine donors have been developed that leverage chemical and physical driving forces to overcome this challenging equilibrium. Alongside this strategy, enzyme engineering is typically required to develop TAs compatible with these non-physiological amine donors and the unnatural reaction conditions they require. We herein disclose N-phenylputrescine (NPP) as a readily accessible amine donor, inspired by the biosynthesis of the dipyrroloquinoline alkaloids. NPP is compatible with a broad range of synthetically useful TA biocatalysts and performs across an unparalleled variety of reaction conditions (pH and temperature). Synthetic applicability has been demonstrated through the synthesis of the anti-diabetic drug sitagliptin, delivering the product in excellent enantiopurity using just two equivalents of NPP.
Authors
I am an author on this paper
Click your name to claim this paper and add it to your profile.
Reviews
Recommended
No Data Available